Description:

• Designed. Proven. Transforming.

  • • Designed: L4-L5 is one of the most common sites of spinal pathology. XLIF is a lateral procedure specifically designed to effectively and reproducibly treat pathologies at L4–L5 and above.¹

    • Proven: XLIF is proven to be effective and reproducible at addressing pathologies at L4–L5 and above. It is clinically validated, with over 400 peer-reviewed articles.¹ Over 200,000 XLIF procedures have been completed, and 75% of the cases reported in the literature included L4–L5. XLIF has demonstrated superior and more predictable outcomes than traditional spinal fusion procedures, with substantially fewer complications.^{1,2,3 - 5}

    • Transforming: The introduction of XLIF transformed the minimally invasive surgery spine market. XLIF continues to transform patients’ lives, transform surgical practices, and transform hospitals’ ability to provide superior, best-in-care patient results, while maintaining and demonstrating economic value.

References:

1. Lehmen JA, Gerber EJ. MIS lateral spine surgery: A systematic literature review of complications, outcomes, and economics.Eur Spine J 2015;24(Suppl 3):287-313.

2. Cheng I, Briseno MR, Arrigo RT, et al. Outcomes of two different techniques using the lateral approach for lumbar interbody arthrodesis.Global Spine J 2015;5(4):308-14.

3. Khajavi K, Shen A, Lagina M, et al. Comparison of clinical outcomes following minimally invasive lateral interbody fusion stratified by preoperative diagnosis. Eur Spine J 2015;24(Suppl3):322-30.

4. Okuda S, Miyauchi A, Oda T, et al. Surgical complications of posterior lumbar interbody fusion with total facetectomy in 251 patients. J Neurosurg Spine 2006;4(4):304-9.

5. Scaduto AA, Gamradt SC, Yu WD, et al. Perioperative complications of threaded cylindrical lumbar interbody fusion devices: anterior versus posterior approach. J Spinal Disord Tech 2003;16(6):502-7.